Rationale and Design of Neuro-Ttransform, a Phase 3 Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx (ion-682884) in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (hATTR-PN)-MedSci.cn

Rationale and Design of Neuro-Ttransform, a Phase 3 Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx (ion-682884) in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (hATTR-PN)

Khella, S; Gertz, MA; Berk, JL; Tai, LJ; Viney, NJ; Monteiro, C; Buchele, G; Brambatti, M; Tsimikas, S; Jung, STW; O'Dea, LSL; Schneider, E; Geary, RS; Monia, BP

ANNALS OF NEUROLOGY, 2020; 88 (): S228

科室
- - 订阅+
  - 更多科室
工具
服务